novo nordisk semaglutide shortage Ozempic's patent problem: how lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Wegovy Obesity Drug Shortage: Novo

If you experience a suspected side effect from any topical product, including cosmetic formulations, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk

Many people start their journey hoping for physical changes, but the transformation often reaches far deeper, influencing energy levels, confidence, daily habits, and overall well-being

Other formulations like Ozempic, Mounjaro, and Rybelsus are approved for diabetes but not specifically for weight management

Consolidated extraction and conversion of baicalin to baicalein from Oroxylum indicum using a novel NADES-UAE system and bioactivity evaluation in RAW 264.7 cells